- Home
- BKH vs KRYS Comparison
BKH vs KRYS Comparison
Compare BKH & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKH
- KRYS
- Stock Information
- Founded
- BKH 1941
- KRYS 2015
- Country
- BKH United States
- KRYS United States
- Employees
- BKH N/A
- KRYS N/A
- Industry
- BKH Electric Utilities: Central
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BKH Utilities
- KRYS Health Care
- Exchange
- BKH Nasdaq
- KRYS Nasdaq
- Market Cap
- BKH 4.3B
- KRYS 3.6B
- IPO Year
- BKH N/A
- KRYS 2017
- Fundamental
- Price
- BKH $58.54
- KRYS $130.91
- Analyst Decision
- BKH Hold
- KRYS Strong Buy
- Analyst Count
- BKH 4
- KRYS 8
- Target Price
- BKH $63.75
- KRYS $211.13
- AVG Volume (30 Days)
- BKH 454.1K
- KRYS 432.0K
- Earning Date
- BKH 07-30-2025
- KRYS 05-06-2025
- Dividend Yield
- BKH 4.61%
- KRYS N/A
- EPS Growth
- BKH N/A
- KRYS 109.01
- EPS
- BKH 3.95
- KRYS 4.16
- Revenue
- BKH $2,206,500,000.00
- KRYS $333,448,000.00
- Revenue This Year
- BKH $4.90
- KRYS $48.66
- Revenue Next Year
- BKH $3.27
- KRYS $49.81
- P/E Ratio
- BKH $14.82
- KRYS $31.43
- Revenue Growth
- BKH 3.28
- KRYS 247.53
- 52 Week Low
- BKH $51.66
- KRYS $122.80
- 52 Week High
- BKH $65.59
- KRYS $219.34
- Technical
- Relative Strength Index (RSI)
- BKH 47.67
- KRYS 40.45
- Support Level
- BKH $57.37
- KRYS $123.03
- Resistance Level
- BKH $58.79
- KRYS $127.59
- Average True Range (ATR)
- BKH 0.95
- KRYS 4.54
- MACD
- BKH 0.03
- KRYS 1.19
- Stochastic Oscillator
- BKH 66.50
- KRYS 62.41
About BKH Black Hills Corporation
Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.